In the present study, we also found a significant prognostic effect of PLK1, with expression in different subtypes of the prostate gland also differing significantly from normal samples, and found that PLK1 expression was also associated with tumor-infiltrating immune cells, further demonstrating the reliability of PLK1 as a biomarker for PCa. Here, PLK1 is linked to neoplasm.